Mindray Medical International has entered into a definitive agreement to purchase a controlling stake of Hangzhou Optcla Medical Instrument.
Optcla provides rigid endoscopes, surgical instruments and consumables as well as distributes various patient monitoring, in-vitro diagnostic and medical imaging products.
Mindray chief strategic officer Minghe Cheng said the acquisition enables the company to gain access to minimally invasive surgery devices and the related surgery consumable market.
"This acquisition will further supplement and extend Mindray’s existing total operation room solutions to cater for the increasing demand for minimally invasive and digitized operations," Cheng added.